Corticosteroid Treatment for Mild Asthmatic Conditions in Adults

Dosage and Administration

The American College of Allergy and Clinical Immunology recommends a dosage of 40-80 mg of methylprednisolone for adults with mild asthmatic conditions, administered intravenously or intramuscularly, until the maximum expiratory flow reaches 70% of the predicted or personal best value 1
The administration can be done through both intravenous and intramuscular routes, with both being equally effective for asthma treatment, according to the Journal of Allergy and Clinical Immunology 2

The treatment with systemic corticosteroids should continue until symptoms stabilize or return to normal function, as stated by the Thorax journal 3
Generally, this is recognized when the maximum expiratory flow is above 75% of the predicted or best level, with a diurnal variability of less than 25% and no nocturnal symptoms, according to the Thorax journal 3
For outpatient treatments, a "burst" of 40-60 mg in one or two divided doses for a total of 5-10 days is recommended, as suggested by the Journal of Allergy and Clinical Immunology and the Thorax journal 1, 2

Systemic corticosteroids are essential for treating the inflammatory component of asthmatic exacerbations and should be administered early, as their anti-inflammatory effects may not be apparent for 6-12 hours, according to the Praxis Medical Insights 2
Measuring and recording the maximum expiratory flow 15-30 minutes after initiating treatment and subsequently according to response is crucial, as stated by the Thorax journal 3, 4
Administering short-acting beta agonists inhalers, such as salbutamol 2.5-5 mg every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed, is recommended, according to the Journal of Allergy and Clinical Immunology 1
Considering adding nebulized ipratropium bromide (0.5 mg) to the beta agonist for severe exacerbations is suggested, as stated by the Thorax journal 4